| Net loss | 113.27M |
| Depreciation | 104.1M |
| Amortization | 191.14M |
| Deferred income tax benefit | |
| Amortization of debt issuance costs | |
| Amortization of debt discount/premium, net | |
| Provision for uncollectible accounts receivable and advances | 12.74M |
| Non-cash loss on extinguishment of debt | |
| Non-cash compensation expense | 25.24M |
| Unrealized changes in fair value of contingent consideration | |
| Loss on sale of operating assets | |
| Equity in earnings of nonconsolidated affiliates | 25.74M |
| Other, net | |
| Increase in accounts receivable | -345.34M |
| Increase in prepaid expenses | |
| Increase in other assets | |
| Increase in accounts payable, accrued expenses and other liabilities | |
| Increase in deferred revenue | -116.35M |
| Net cash provided by operating activities | 119.52M |
| Collections (advances) of notes receivable | |
| Distributions from nonconsolidated affiliates | |
| Investments made in nonconsolidated affiliates | -18.63M |
| Purchases of property, plant and equipment | -119.74M |
| Proceeds from disposal of operating assets, net of cash divested | |
| Cash paid for acquisitions, net of cash acquired | -113.07M |
| Purchases of intangible assets | |
| Other, net | -770K |
| Net cash provided by (used in) investing activities | -260.17M |
| Proceeds from long-term debt, net of issuance costs | |
| Payments on long-term debt | -28.8M |
| Redemption of preferred stock | |
| Contributions from noncontrolling interests | |
| Distributions to and purchases/sales of noncontrolling interests | |
| Proceeds from exercise of stock options | 5.68M |
| Proceeds from sale of common stock | |
| Equity issuance costs | |
| Purchases of common stock | |
| Payments for deferred and contingent consideration | -21.81M |
| Net cash provided by (used in) financing activities | -109.7M |
| Effect of exchange rate changes on cash and cash equivalents | -13.06M |
| Net increase in cash and cash equivalents | -263.42M |
| Cash and cash equivalents at beginning of period | 1.3B |
| Cash and cash equivalents at end of period | 1.04B |